In patients with pancreatic cancer, Treg cells are an important component involved in the inhibition of tumor immune response by disordering the functions of CD4+ T and CD8+ T cells, macrophages, NK cells and DC cells (105, 106). This evidence concerns the gene CD4 and neoplasm.